Regulatory Resources
Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools
Benefit-Risk Factors to Consider When Determining Substantial Equivalence in 510(k) Submissions
Final FDA guidance on 510(k). Published 2018 by CDRH/CBER.
Download PDFManufacturing Site Change Supplements: Content and Submission
Final FDA guidance on manufacturing. Published 2018 by CDRH/CBER.
Download PDFUser Fees and Refunds for Premarket Approval Applications and Device BLAs
Final FDA guidance on user fees. Published 2018 by CDRH/CBER.
Download PDFThe Least Burdensome Provisions: Concept and Principles
Final FDA guidance on submission process. Published 2019 by CDRH/CBER.
Download PDFUnique Device Identification: Convenience Kits
Final FDA guidance on udi. Published 2019 by CDRH/CBER.
Download PDFFactors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo
Final FDA guidance on benefit-risk. Published 2019 by CDRH/CBER.
Download PDFHumanitarian Device Exemption (HDE) Program
Final FDA guidance on hde. Published 2019 by CDRH/CBER.
Download PDFThe Special 510(k) Program
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
Download PDFThe Abbreviated 510(k) Program
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
Download PDFRefuse to Accept Policy for 510(k)s
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
Download PDF